Your browser doesn't support javascript.
loading
Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines.
Gomez, Gabriela Beatriz; Siapka, Mariana; Conradie, Francesca; Ndjeka, Norbert; Garfin, Anna Marie Celina; Lomtadze, Nino; Avaliani, Zaza; Kiria, Nana; Malhotra, Shelly; Cook-Scalise, Sarah; Juneja, Sandeep; Everitt, Daniel; Spigelman, Melvin; Vassall, Anna.
Afiliação
  • Gomez GB; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK gabriela.gomez@lshtm.ac.uk.
  • Siapka M; Modelling, Epidemiology and Data Science Department, Sanofi Pasteur, Lyon, France.
  • Conradie F; Department of Global Health and Development, Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
  • Ndjeka N; Impact Epilysis, Thessaloniki, Greece.
  • Garfin AMC; Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
  • Lomtadze N; National TB Programme, South Africa Department of Health, Pretoria, Gauteng, South Africa.
  • Avaliani Z; National Tuberculosis Control Program, Bureau of Disease Prevention and Control, Department of Health, Manila, The Philippines.
  • Kiria N; Department of TB Surveillance and Strategic Planning, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Malhotra S; Department of TB Surveillance and Strategic Planning, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Cook-Scalise S; Department of TB Surveillance and Strategic Planning, National Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
  • Juneja S; TB Alliance, New York, New York, USA.
  • Everitt D; Global Access, International AIDS Vaccine Initiative (IAVI), New York, New York, USA.
  • Spigelman M; TB Alliance, New York, New York, USA.
  • Vassall A; TB Division, USAID, Washington, DC, USA.
BMJ Open ; 11(12): e051521, 2021 12 03.
Article em En | MEDLINE | ID: mdl-34862287

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / America do norte / Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Tuberculose Extensivamente Resistente a Medicamentos Tipo de estudo: Health_economic_evaluation / Risk_factors_studies Limite: Humans País/Região como assunto: Africa / America do norte / Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article